NASDAQ · Financial Statements

Seaport Therapeutics, Inc. Common Stock (SPTX) Financial Statements

$20.61 NASDAQ: SPTX Market Cap $1.10B

Seaport Therapeutics, Inc. Common Stock most recently reported annual revenue of $0, a net loss of $75.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Income Statement — 1 Years (USD millions)

Metric2025
Revenue$0
Operating Expenses$87.0M
Operating Profit$-87.0M
Operating Margin0.0%
Other Income$13.0M
Interest$0
Depreciation$1.0M
Profit Before Tax$-74.0M
Tax$-1.0M
Net Profit$-75.0M
EPS$-1.94
Dividend Payout0.0%

Quarterly Results — Last 2 Quarters (USD millions)

MetricMar '26Jun '26
Revenue$0$0
Operating Expenses$28.0M$66.0M
Operating Profit$-28.0M$-66.0M
Operating Margin0.0%0.0%
Interest$0$0
Profit Before Tax$-25.0M$-63.0M
Tax$-2.1M$-20,000
Net Profit$-25.0M$-63.0M
EPS$-0.48$-1.17

Balance Sheet — 1 Years (USD millions)

Metric2025
Total Assets$249.0M
Current Assets$223.0M
Cash$46.0M
Inventory$0
Receivables$3.0M
Fixed Assets$5.0M
Capital Work in Progress$0
Investments$188.0M
Other Assets$0
Total Liabilities$342.0M
Current Liabilities$13.0M
Borrowings$5.0M
Other Liabilities$336.0M
Equity$0
Reserves$-93.0M

Cash Flow Statement — 1 Years (USD millions)

Metric2025
Operating Cash Flow$-78.0M
Investing Cash Flow$-185.0M
Financing Cash Flow$-1.0M
Net Cash Flow$-263.0M
Free Cash Flow$-78.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.12
EV / EBITDA-11.27
FCF Yield-4.20%
Quick Ratio18.00
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Seaport Therapeutics, Inc. Common Stock (SPTX) financials — frequently asked questions

What is Seaport Therapeutics, Inc. Common Stock's annual revenue?

Seaport Therapeutics, Inc. Common Stock (SPTX) reported annual revenue of $0 in its most recent fiscal year.

What is Seaport Therapeutics, Inc. Common Stock's net profit?

Seaport Therapeutics, Inc. Common Stock (SPTX) reported a net loss of $75.0M in its most recent fiscal year.

What is SPTX EV/EBITDA?

Seaport Therapeutics, Inc. Common Stock's enterprise value to EBITDA (EV/EBITDA) ratio is -11.27. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
SPTX Overview SPTX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.